Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Modified adenovirus serotype 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand and full length 4-1BBL

EU orphan designation number: EU/3/15/1516   
Active ingredient: Modified adenovirus serotype 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand and full length 4-1BBL
Indication: Treatment of pancreatic cancer
Sponsor: Lokon Pharma AB
Dag Hammarskjöldsväg 40c, 751 83 Uppsala, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
3/08/2015 Orphan designation EMA/OD/034/15 (2015)5422 of 28/07/2015